Sellas Life Sciences shares fall 15% to $10.38
Sellas Life Sciences shares ended Wednesday 15% lower at $10.38 as the company moved closer to a key cancer-drug readout.
Sellas Life Sciences (SLS) moved closer to a key cancer-drug readout Wednesday, but its shares tumbled nearly 15%, leaving retail bulls buying the dip and betting the upcoming results could reverse the slide.SLS stock ended 15% lower on Wednesday at $10.38, logging its worst day in nearly five mont…